Hikal Ltd Share Price

Overview

Hikal Ltd share price is currently ₹209.00, down by - ₹4.46 (2.09%) from its previous closing price of ₹213.46. The share price has declined -2.06% over the past month and declined -15.38% over the past year. The stock's 52-week low and high are ₹143.79 and ₹280.23, respectively. Hikal Ltd has a market capitalisation of ₹ 2,660.00 Cr. The share price was last updated on 24 Aug 2026, 03:29 PM IST.

Hikal Ltd

HIKAL

₹0.00

- ₹4.46

2.09%

Healthcare

₹0.00(%)1D

Updated: 24 Aug 2026, 03:29:55 pm IST

Market Data

Open Price

₹208.00

Prev. Close

₹213.46

₹207.32

Day Low

₹210.01

Day High

₹143.79

52 Week Low

₹280.23

52 Week High

HealthcarePharmaceuticals & Drugs

CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

-76.28

Sector PE

42.03

PB Ratio

2.04

Sector PB

5.82

EPS

-2.74

Dividend Yield

0.35

Today's Volume

190.421 K

5 Day Avg. Volume

147.830 K

PEG Ratio

-2.50

Market Cap.

₹ 2,660.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsInterim Dividend of 10% at ₹0.2/Share	17-Feb-2026	17-Feb-2026
DividendsFinal Dividend of 40% at ₹0.8/Share	02-Sep-2025	02-Sep-2025
DividendsInterim Dividend of 30% at ₹0.6/Share	07-Feb-2025	07-Feb-2025
DividendsFinal Dividend of 30% at ₹0.6/Share	04-Sep-2024	04-Sep-2024

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth	40.00 Lac	36.41 Lac (8.97%)
Tata Small Cap Fund - Regular Plan - Growth	33.00 Lac	33.00 Lac no change
Motilal Oswal BSE Healthcare ETF	991	1.01 k (2.22%)
Bandhan BSE Healthcare Index Fund - Regular Plan - Growth	508	544 (7.09%)
Motilal Oswal BSE 1000 Index Fund - Regular Plan - Growth	112	110 (1.79%)

Show all holdings

About Hikal Ltd 👋

Hikal Limited is an India-based company, which is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. The Pharmaceuticals segment produces active pharmaceutical ingredients. Its facilities are in Jigani, Bangalore and Panoli, Gujrat. The Crop protection segment produces pesticides and herbicides. Its facilities are in Taloja, Mahad, Maharashtra and Panoli, Gujarat. Its human health product categories include anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, and hemorheologic. Its animal health product categories include anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID. Its crop protection products are used in algaecide, biocide, fungicide, herbicide, insecticide, and intermediate. It offers contract research services for synthesis, process development, and manufacturing projects.